Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Intellia Therapeutics awarded inducement grants to eight new employees on August 1, 2026, pursuant to its 2024 Inducement Plan. The grants consist of an aggregate of 38,200 time-based restricted stock units, with one-third vesting annually over three years.
Key figures
- New hires
- 8
- Vesting years
- 3
- Shares granted
- 38200
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.